EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H29N5O2S |
| Net Charge | 0 |
| Average Mass | 427.574 |
| Monoisotopic Mass | 427.20420 |
| SMILES | CC(NN1CCCCC1c1cccnc1)=C1C(=O)NC(=S)N(C2CCCCC2)C1=O |
| InChI | InChI=1S/C22H29N5O2S/c1-15(25-26-13-6-5-11-18(26)16-8-7-12-23-14-16)19-20(28)24-22(30)27(21(19)29)17-9-3-2-4-10-17/h7-8,12,14,17-18,25H,2-6,9-11,13H2,1H3,(H,24,28,30) |
| InChIKey | JSLFMQXCOCNGKU-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 1-cyclohexyl-5-[1-[[2-(3-pyridinyl)-1-piperidinyl]amino]ethylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione (CHEBI:108401) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-19777 | LINCS |